Chen and colleagues, using a large multicenter prospective study, show the feasibility and survival benefits of annual screening for hepatocellular carcinoma in individuals at high risk based on hepatitis B surface antigen seropositivity.
- Hongmei Zeng
- Maomao Cao
- Wanqing Chen